cardiovascular disease

August 20, 2020

Salt, immune cells and hypertension

Excess dietary salt activates immune cells to induce inflammation and hypertension, supporting current recommendations for low sodium consumption.

By Leigh MacMillan
July 27, 2020

Soy food, metabolism and the microbiome

Consumption of soy foods may shape the microbiome and protect against hypertension only in individuals with soy-responsive microbiota, Vanderbilt researchers have discovered.

By Sarah E. Glass
October 31, 2019

Acute kidney injury recovery time impacts future risk

Interventions that impact the timing of recovery following acute injury may improve future outcomes for patients.

By Danielle Kopke
October 7, 2019

AI maps routes to heart disease

Machine learning on unlabeled electronic health record data has shed light on the emergence of cardiovascular disease.

By Paul Govern
From left, Ryan Allen, PhD, MacRae Linton, MD, Kasey Vickers, PhD, Quanhu Sheng, PhD, and colleagues are working to create a new model of atherosclerosis development. (photo by Susan Urmy)
August 26, 2019

VUMC investigators receive Keck Foundation award for novel atherosclerosis research

A team of researchers has received a $1 million grant from the W.M. Keck Foundation to explore a novel model of atherosclerosis development.

By Leigh MacMillan
August 20, 2019

Quitting smoking associated with lower risk of cardiovascular disease

A new Vanderbilt study documents the great incentive for current smokers to quit.

By Matt Batcheldor
September 20, 2018

New HIV research training program launched

With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.
By Paul Govern
June 21, 2018

Roden’s circulatory diseases research honored

Jun. 21, 2018—Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.
By Bill Snyder
June 21, 2018

Roden’s circulatory diseases research honored

Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.
By Bill Snyder
May 3, 2018

Understanding HDL structure

Structural features of newly formed HDL particles will help guide understanding of “good cholesterol” and its function.
By Leigh MacMillan
May 17, 2016

Study finds menthol cigarettes do not further increase smokers’ cardiovascular disease, stroke risk

Smoking is deleterious to health, but smokers who prefer menthol cigarettes to nonmenthol can breathe a sigh of relief…for now.
By Kathy Whitney
October 8, 2015

Depression poses heart risk for HIV patients: study

The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation.
By Kathy Whitney
1 2 3 4